Form D/A - Notice of Exempt Offering of Securities: [Amend]
SEC Accession No. 0001667699-22-000003
Filing Date
2022-08-22
Accepted
2022-08-22 16:48:15
Documents
1
Effectiveness Date
2022-08-22
Items
Item 06b:

Document Format Files

Seq Description Document Type Size
1 primary_doc.html D/A  
1 primary_doc.xml D/A 10285
  Complete submission text file 0001667699-22-000003.txt   11363
Mailing Address 950 E. STATE HIGHWAY 114 STE-160 SOUTHLAKE TX 76092
Business Address 950 E. STATE HIGHWAY 114 STE-160 SOUTHLAKE TX 76092 386-527-1071
Renibus Therapeutics, Inc. (Filer) CIK: 0001667699 (see all company filings)

EIN.: 810872431 | State of Incorp.: DE | Fiscal Year End: 1231
Type: D/A | Act: 33 | File No.: 021-454246 | Film No.: 221184261